4.5 Article

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection

期刊

EUROPEAN JOURNAL OF IMMUNOLOGY
卷 39, 期 4, 页码 1007-1018

出版社

WILEY
DOI: 10.1002/eji.200838814

关键词

IFN regulatory factor; Murine cytomegalovirus; NK cells; Type I IFN

资金

  1. German Research Foundation [SFB455, SFB571, KR2199/1-3]

向作者/读者索取更多资源

IFN regulatory factor 7 (IRF7) has been described as the master regulator of type I IFN responses and has been shown to be critical for innate antiviral immunity in vivo. In addition to type I IFN, NK cell responses are involved in the control of viral replication during acute viral infection. To investigate the role of IRF7 in the context of a viral infection that induces a strong NK cell response, the murine cytomegalovirus (MCMV) infection model was used. WT, IRF7-deficient and IRF3/IRF7-double deficient mice were infected with MCMV. The systemic IFN-alpha response to MCMV was entirely dependent on IRF7, but independent of IRF3. However, peak IFN-beta production during MCMV infection was not affected by the lack of IRF7 or both IRF7 and IRF3. Despite the complete lack of IFN-alpha production IRF7- and IRF3/IRF7-deficient mice were surprisingly efficient in controlling MCMV replication and were only modestly more susceptible to MCMV infection than WT mice. NK cell cytotoxicity was unimpaired and NK cell IFN-gamma production was enhanced in IRF7-deficient mice correlating with increased levels of bioactive IL-12. Owing to these compensatory mechanisms IRF7-dependent antiviral immune responses were not essential for resistance against acute MCMV infection in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Comparative Study of the Role of Interepithelial Mucosal Mast Cells in the Context of Intestinal Adenoma-Carcinoma Progression

Tanja Groll, Miguel Silva, Rim Sabrina Jahan Sarker, Markus Tschurtschenthaler, Theresa Schnalzger, Carolin Mogler, Daniela Denk, Sebastian Schoelch, Barbara U. Schraml, Jurgen Ruland, Roland Rad, Dieter Saur, Wilko Weichert, Moritz Jesinghaus, Kaspar Matiasek, Katja Steiger

Summary: The study found that the number of ieMMCs decreases as the disease progresses from low-grade adenomas to carcinomas in intestinal cancer, and that ieMMC scores were higher in mouse models with altered Wnt signaling compared to models with altered MAPK signaling. ieMMCs play an important role in the tumor microenvironment, particularly in relation to the onset and progression of intestinal cancer.

CANCERS (2022)

Article Immunology

Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination

Elena Winheim, Tabea Eser, Flora Deak, Mohamed I. M. Ahmed, Olga Baranov, Linus Rinke, Katharina Eisenacher, Antonio Santos-Peral, Hadi Karimzadeh, Michael Pritsch, Clemens Scherer, Maximilian Muenchhoff, Johannes C. Hellmuth, Michael Von Bergwelt-Baildon, Laura Olbrich, Michael Hoelscher, Andreas Wieser, Inge Kroidl, Simon Rothenfusser, Christof Geldmacher, Anne B. Krug

Summary: Dysregulation of myeloid cell compartment is observed in severe COVID-19 patients. In this study, the response of circulating dendritic cells (DCs) and monocytes was compared between SARS-CoV-2 infected outpatients and individuals receiving yellow fever vaccine virus. The majority of COVID-19 outpatients showed similarities in their immune response with YF17D vaccination, while a subgroup of patients exhibited dysregulated activation of blood DCs and monocytes.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Immunology

The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice

Emma Morrish, Tim Wartewig, Andreas Kratzert, Marc Rosenbaum, Katja Steiger, Juergen Ruland

Summary: VAV1-MYO1F is a newly identified fusion protein that is frequently detected in T-cell non-Hodgkin's lymphoma (T-NHL) patients. The pathophysiological functions of VAV1-MYO1F in lymphomagenesis are not well defined. In this study, transgenic mouse models were generated to conditionally express VAV1-MYO1F in T-cells. The results demonstrate that VAV1-MYO1F triggers cell autonomous activation of T-cell signaling and induces aberrant T-cell differentiation, proliferation, and neoplastic transformation.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Cell Biology

STAT3 signaling induced by the IL-6 family of cytokines modulates angiogenesis

Julian Rapp, Malte Jung, Rhena F. U. Klar, Julian Wolf, Jakob Arnold, Oliver Gorka, Olaf Gross, Clemen Lange, Hansjurgen Agostini, Guenther Schlunck, Felicitas Bucher

Summary: Aberrant angiogenesis is a hallmark of cardiovascular and retinal neovascular disease. The STAT3 signaling pathway represents a potential pharmacological target for these diseases due to its impact on angiogenesis. However, the effects of STAT3 activation on angiogenesis vary depending on the specific cytokine.

JOURNAL OF CELL SCIENCE (2023)

Article Immunology

Human TH17 cells engage gasdermin E pores to release IL-1a on NLRP3 inflammasome activation

Ying-Yin Chao, Alisa Puhach, David Frieser, Mahima Arunkumar, Laurens Lehner, Thomas Seeholzer, Albert Garcia-Lopez, Marlot van der Wal, Silvia Fibi-Smetana, Axel Dietschmann, Thomas Sommermann, Tamara Cikovic, Leila Taher, Mark S. Gresnigt, Sebastiaan J. Vastert, Femke van Wijk, Gianni Panagiotou, Daniel Krappmann, Olaf Gross, Christina E. Zielinski

Summary: In this study, it was discovered that human T cells express GSDME, which is associated with durable viability and the release of IL-1 alpha. This property is only present in a subset of human helper type 17 T cells with specificity for Candida albicans, regulated by the T cell-intrinsic NLRP3 inflammasome. The release of IL-1 alpha is mediated by a proteolytic cascade involving caspase-8, caspase-3, and GSDME cleavage, as well as T cell receptor stimulation and calcium-licensed calpain maturation of pro-IL-1 alpha form. This finding expands our understanding of the functional diversity and mechanism of T cells and has implications for antifungal immunity.

NATURE IMMUNOLOGY (2023)

Article Cell Biology

SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD

Laura Griewahn, Madeleine Mueller-Foxworth, Lukas Peintner, Manuela Wissler, Martina Weiss, Prisca Brauns-Schubert, Ramin Massoumi, Christoph Borner, Olaf Gross, Monica Yabal, Celine Charvet, Ulrich Maurer

Summary: SPATA2 bridges the interaction between CYLD and HOIP, a component of the LUBAC, thereby mediating the recruitment of CYLD to immune receptor complexes. In addition, SPATA2 competes with OTULIN for binding to HOIP, promoting autoubiquitylation of LUBAC and attenuating pro-inflammatory signaling. These findings highlight the independent functions of SPATA2 and CYLD in immune regulation.

CELL REPORTS (2023)

Article Biochemistry & Molecular Biology

CLEC12A Binds to Legionella pneumophila but Has No Impact on the Host's Antibacterial Response

Ann-Brit Klatt, Christina Diersing, Juliane Lippmann, Sabine Mayer-Lambertz, Felix Stegmann, Swantje Fischer, Sandra Caesar, Facundo Fiocca Vernengo, Katja Hoenzke, Andreas C. Hocke, Juergen Ruland, Martin Witzenrath, Bernd Lepenies, Bastian Opitz

Summary: CLEC12A can bind to Legionella pneumophila-derived ligands, but it does not play a major role in the innate defense against the bacterium.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

Jana Zecha, Florian P. Bayer, Svenja Wiechmann, Julia Woortman, Nicola Berner, Julian Mueller, Annika Schneider, Karl Kramer, Mar Abril-Gil, Thomas Hopf, Leonie Reichart, Lin Chen, Fynn M. Hansen, Severin Lechner, Patroklos Samaras, Stephan Eckert, Ludwig Lautenbacher, Maria Reinecke, Firas Hamood, Polina Prokofeva, Larsen Vornholz, Chiara Falcomata, Madeleine Dorsch, Ayla Schroeder, Anton Venhuizen, Stephanie Wilhelm, Guillaume Medard, Gabriele Stoehr, Juergen Ruland, Barbara M. Gruener, Dieter Saur, Maike Buchner, Benjamin Ruprecht, Hannes Hahne, Matthew The, Mathias Wilhelm, Bernhard Kuster

Summary: A proteomic assay called decryptM is introduced to quantify drug-regulated posttranslational modifications (PTMs) for thousands of PTMs in cells, providing insights into target engagement and drug mechanisms. The approach is shown to be applicable across 31 cancer drugs and 13 cell lines. The resulting 1.8 million dose-response curves are provided as an interactive molecular resource in ProteomicsDB, expanding the utility of the research.

SCIENCE (2023)

Article Multidisciplinary Sciences

The impact of metabolic stressors on mitochondrial homeostasis in a renal epithelial cell model of methylmalonic aciduria

Anke Schumann, Marion Brutsche, Monique Havermans, Sarah C. Gruenert, Stefan Koelker, Olaf Gross, Luciana Hannibal, Ute Spiekerkoetter

Summary: Methylmalonic aciduria (MMA-uria) is a condition caused by a lack of the enzyme methylmalonyl-CoA mutase (MUT) in mitochondria. It affects energy generation from certain amino acids, fatty acids, and cholesterol. Chronic kidney disease (CKD) is a known complication of MMA-uria. Research has shown that MMA-uria cells have increased creatinine levels and decreased antioxidant defense. Mitochondrial homeostasis is disrupted, with changes in metabolites and impaired energy generation from fatty acid oxidation. Potentially toxic metabolite methylcitrate is increased under high protein and isoleucine/valine conditions. Mitophagy is disabled, while autophagy is active, especially under high protein and isoleucine/valine conditions. Mitochondrial dynamics shift towards fission and the stress-resistance protein Sirtuin1 is down-regulated. Overall, these findings highlight the role of protein toxicity and provide insight into how accumulating toxic organic acids may contribute to CKD in MMA-uria.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy

Larsen Vornholz, Sophie E. Isay, Zsuzsanna Kurgyis, Daniel C. Strobl, Patricia Loll, Mohammed H. Mosa, Malte D. Luecken, Michael Sterr, Heiko Lickert, Christof Winter, Florian R. Greten, Henner F. Farin, Fabian J. Theis, Juergen Ruland

Summary: Immune checkpoint inhibitors (ICIs) enhance anticancer immunity by releasing repressive signals into tumor microenvironments (TMEs). This study found that the superior antitumor immune response of mismatch repair (MMR)-deficient colorectal cancer (CRC) required tumor cell-intrinsic activation of cGAS-STING signaling triggered by genomic instability. In MMR-proficient CRC, genetically encoded gain-of-function STING was sufficient to induce cancer cell-intrinsic interferon signaling, local activation of antigen-presenting cells, recruitment of effector lymphocytes, and sensitization of previously cold TMEs to ICI therapy in vivo.

SCIENCE ADVANCES (2023)

Article Gastroenterology & Hepatology

Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8(+) T cells

Frances Winkler, Anna Hipp, Carlos Ramirez, Bianca Martin, Matteo Villa, Emilia Neuwirt, Oliver Gorka, Jeroen Aerssens, Susanne E. Johansson, Nisha Rana, Sian Llewellyn-Lacey, David A. Price, Marcus Panning, Olaf Gross, Erika L. Pearce, Carl M. Hermann, Kathrin Schumann, Luciana Hannibal, Christoph Neumann-Haefelin, Tobias Boettler, Percy Knolle, Maike Hofmann, Dirk Wohlleber, Robert Thimme, Bertram Bengsch

Summary: Exhausted T cells with limited function are common in chronic HBV and HCV infection, but the relationship between metabolism and exhaustion states, the impact of antiviral therapy, and the role of metabolic checkpoints in dysfunction are not fully understood.
Article Cell Biology

Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression

Veronika Ecker, Lisa Brandmeier, Martina Stumpf, Piero Giansanti, Aida Varela Moreira, Lisa Pfeuffer, Marcel H. . A. M. Fens, Junyan Lu, Bernhard Kuster, Thomas Engleitner, Simon Heidegger, Roland Rad, Ingo Ringshausen, Thorsten Zenz, Clemens-Martin Wendtner, Markus Muschen, Julia Jellusova, Jurgen Ruland, Maike Buchner

Summary: Inhibition of the phosphatases DUSP1 and DUSP6 reduces cell survival and induces cell death in chronic lymphocytic leukemia. Transient inhibition of DUSP1/6 shows promise as a treatment concept for drug-resistant CLL.

CELL REPORTS (2023)

Article Medicine, General & Internal

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors

Laura Joachim, Sascha Goettert, Anna Sax, Katja Steiger, Klaus Neuhaus, Paul Heinrich, Kaiji Fan, Erik Thiele Orberg, Karin Kleigrewe, Juergen Ruland, Florian Bassermann, Wolfgang Herr, Christian Posch, Simon Heidegger, Hendrik Poeck

Summary: The composition of the gut microbiome is associated with the response to immune checkpoint inhibitors (ICI). In this study, the researchers found that oral supplementation of a bacterial metabolite called desaminotyrosine (DAT) delays tumor growth and enhances ICI immunotherapy. This enhanced antitumor immunity is dependent on host IFN-I signaling and is associated with increased activation of T cells and natural killer cells in the tumor environment. DAT supplementation also compensates for the negative effects of broad-spectrum antibiotics on ICI immunotherapy by altering the gut microbial composition.

EBIOMEDICINE (2023)

Article Oncology

PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma

Tim Wartewig, Jay Daniels, Miriam Schulz, Erik Hameister, Abhinav Joshi, Joonhee Park, Emma Morrish, Anuroop V. Venkatasubramani, Filippo M. Cernilogar, Frits H. A. van Heijster, Christian Hundshammer, Heike Schneider, Filippos Konstantinidis, Judith V. Gabler, Christine Klement, Henry Kurniawan, Calvin Law, Yujin Lee, Sara Choi, Joan Guitart, Ignasi Forne, Jerome Giustinani, Markus Mueschen, Salvia Jain, David M. Weinstock, Roland Rad, Nicolas Ortonne, Franz Schilling, Gunnar Schotta, Axel Imhof, Dirk Brenner, Jaehyuk Choi, Juergen Ruland

Summary: PD-1 signaling suppresses T cell malignancy by restricting glycolytic energy and acetyl coenzyme A production. Inactivation of PD-1 strengthens ATP citrate lyase activity, leading to extramitochondrial acetyl-CoA production for hyperactivation of AP-1. Pharmacological inhibition of ATP citrate lyase impedes aberrant AP-1 signaling and is toxic to PD-1-deficient T-NHLs.

NATURE CANCER (2023)

Article Cell Biology

Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy

Simon Heidegger, Florian Stritzke, Sarah Dahl, Juliane Dassler-Plenker, Laura Joachim, Dominik Buschmann, Kaiji Fan, Carolin M. Sauer, Nils Ludwig, Christof Winter, Stefan Enssle, Suqi Li, Markus Perl, Andre Goergens, Tobias Haas, Erik Thiele Orberg, Sascha Goettert, Catherine Woelfel, Thomas Engleitner, Isidro Cortes-Ciriano, Roland Rad, Wolfgang Herr, Bernd Giebel, Jurgen Ruland, Florian Bassermann, Christoph Coch, Gunther Hartmann, Hendrik Poeck

Summary: Tumor-derived extracellular vesicles (EVs) play a role in immune evasion and tumor progression through the RNA-sensing receptor RIG-I. Activation of RIG-I releases EVs that promote dendritic cell maturation and T cell antitumor immunity, synergizing with immune checkpoint blockade. Intact RIG-I, autocrine interferon signaling, and the GTPase Rab27a are necessary for the generation of immunostimulatory EVs. The composition of the EV RNA cargo, including small non-coding stimulatory RNAs, is regulated by active intrinsic RIG-I signaling. Increased transcriptional activity of EV pathway genes and RIG-I in melanoma samples is associated with prolonged patient survival and positive response to immunotherapy. EVs generated from human melanoma after RIG-I stimulation induce potent antigen-specific T cell responses.

CELL REPORTS MEDICINE (2023)

暂无数据